We all knew process scientists were good, but the Merck and Codexis teams just took it to another level! Unnatural nucleosides like Merck’s reverse transcriptase inhibitor islatravir ( 1 , Figure 1) are well-known to be challenging to synthesize by traditional methods, as evidenced by several published chemical syntheses [...]